Literature DB >> 22735161

Restricted ROC curves are useful tools to evaluate the performance of tumour markers.

S Parodi1, M Muselli2, B Carlini3, V Fontana4, R Haupt5, V Pistoia3, M V Corrias3.   

Abstract

In Clinical Epidemiology, receiver operating characteristic (ROC) analysis is a standard approach for the evaluation of the performance of diagnostic tests for binary classification based on a tumour marker distribution. The area under a ROC curve is a popular indicator of test accuracy, but its use has been questioned when the curve is asymmetric. This situation often happens when the marker concentrations overlap in the two groups under study in the range of low specificity, corresponding to a subset of values useless for classification purposes (non-informative values). The partial area under the curve at a high specificity threshold has been proposed as an alternative, but a method to identify an optimal cut-off that separates informative from non-informative values is not yet available. In this study, a new statistical approach is proposed to perform this task. Furthermore, a statistical test associated with the area under a ROC curve corresponding to informative values only (restricted ROC curve) is provided and its properties are explored by extensive simulations. Finally, the proposed method is applied to a real data set containing peripheral blood levels of six tumour markers proposed for the diagnosis of neuroblastoma. A new approach to combine couples of markers for classification purposes is also illustrated.
© The Author(s) 2012.

Entities:  

Keywords:  Tumour markers; diagnostic tests; receiver operating characteristic analysis; restricted receiver operating characteristic curve

Mesh:

Substances:

Year:  2012        PMID: 22735161     DOI: 10.1177/0962280212452199

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  1 in total

1.  Serum levels of cytoskeleton remodeling proteins and their mRNA expression in tumor tissue of metastatic laryngeal and hypopharyngeal cancers.

Authors:  G V Kakurina; O V Cheremisina; E E Sereda; E S Kolegova; I V Kondakova; E L Choinzonov
Journal:  Mol Biol Rep       Date:  2021-07-06       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.